Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

CNCE

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CNCE
FechaHoraFuenteTítuloSímboloCompañía
26/04/201806:00Business WireConcert Pharmaceuticals to Report First Quarter 2018 Financial Results on May 3, 2018, & Present at Upcoming Investor Confere...NASDAQ:CNCEConcert Pharmaceuticals Inc
25/04/201806:00Business WireConcert Pharmaceuticals Completes Enrollment in Phase 2a Trial of CTP-543 in Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
19/04/201815:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
13/04/201815:52Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
10/04/201807:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
08/03/201805:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/201806:00Business WireConcert Pharmaceuticals Present at Upcoming Investor ConferencesNASDAQ:CNCEConcert Pharmaceuticals Inc
01/03/201806:42Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNCEConcert Pharmaceuticals Inc
01/03/201806:40Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CNCEConcert Pharmaceuticals Inc
01/03/201806:38Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
01/03/201806:00Business WireConcert Pharmaceuticals Reports Year Ended 2017 Financial ResultsNASDAQ:CNCEConcert Pharmaceuticals Inc
28/02/201815:05Business WireConcert Pharmaceuticals Announces Advancement of Novel Drug Candidate in SchizophreniaNASDAQ:CNCEConcert Pharmaceuticals Inc
21/02/201806:00Business WireConcert Pharmaceuticals to Report Full Year 2017 Results on March 1, 2018NASDAQ:CNCEConcert Pharmaceuticals Inc
14/02/201816:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
12/02/201806:00Business WireConcert Pharmaceuticals Announces Initiation of Enrollment in Second Cohort of CTP-543 Phase 2a Trial for Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
09/02/201816:16Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNCEConcert Pharmaceuticals Inc
26/01/201815:21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
12/01/201806:05Business WireFDA Grants Fast Track Designation to Concert Pharmaceuticals’ CTP-543 for the Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
12/01/201806:00Business WireConcert Pharmaceuticals Announces Patent Trial and Appeal Board Did Not Institute PGR ProceedingNASDAQ:CNCEConcert Pharmaceuticals Inc
08/01/201817:22Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CNCEConcert Pharmaceuticals Inc
18/12/201706:00Business WireConcert Pharmaceuticals Announces the Appointment of Marc Becker as Chief Financial OfficerNASDAQ:CNCEConcert Pharmaceuticals Inc
13/12/201706:00Business WireConcert Pharmaceuticals to Be Added to NASDAQ Biotechnology IndexNASDAQ:CNCEConcert Pharmaceuticals Inc
05/12/201708:15GlobeNewswire Inc.Recent Analysis Shows Dextera Surgical, Continental Resources, Western Union, M.D.C., Concert Pharmaceuticals, and WellCare H...NASDAQ:CNCEConcert Pharmaceuticals Inc
09/11/201706:34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNCEConcert Pharmaceuticals Inc
09/11/201706:00Business WireConcert Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Company UpdateNASDAQ:CNCEConcert Pharmaceuticals Inc
06/11/201706:00Business WireConcert Pharmaceuticals Announces Completion of Enrollment in First Cohort of CTP-543 Phase 2a TrialNASDAQ:CNCEConcert Pharmaceuticals Inc
02/11/201706:00Business WireConcert Pharmaceuticals to Report Third Quarter 2017 Financial Results on November 9, 2017, & Participate at Upcoming Investo...NASDAQ:CNCEConcert Pharmaceuticals Inc
19/10/201712:00Business WireConcert Pharmaceuticals Announces PTAB Denies Incyte Petition Challenging CTP-543 PatentNASDAQ:CNCEConcert Pharmaceuticals Inc
31/08/201706:00Business WireConcert Pharmaceuticals Announces Webcast at Wells Fargo Healthcare ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
08/08/201706:00Business WireConcert Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Company UpdateNASDAQ:CNCEConcert Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNCE